The PhRMA Code is a voluntary code of ethics, relating to interactions pharmaceutical companies have with U.S. healthcare professionals. This code provides a collection of detailed rules, as well as broader principles, that have yet to be compiled into a comparable industry or government document.
PhRMA has adjusted its Code on Interactions, partly in response to the Special Fraud Alert issued by the OIG. These changes largely pertain to company-sponsored speaker programs, highlighting fraud and abuse risks with these events. The update was initially announced on August 6, 2021, and will take effect on January 1, 2022.